Search Results - "Kendra, K.L."

A Phase I Study of Bortezomib and Interferon-Alpha-2b in Patients with Metastatic Melanoma by Grignol, V.P, Kendra, K.L, Lesinski, G.B, Olenki, T, Carson, W.E

Get full text

Phase I Study of Trametinib in Combination with Whole-Brain Radiation Therapy for Brain Metastases by Fabian, D., Wuthrick, E.J., Wei, L., Tan, J., Grecula, J.C., Welliver, M.X., Williams, T.M., Elder, J.B., Raval, R., Blakaj, D.M., Haglund, K.E., Bazan, J.G., Kendra, K.L., Liebner, D., Puduvalli, V., Giglio, P., Gonzalez, J., Arnett, A.L.H., Bell, E.H., Chakravarti, A., Palmer, J.D.

Get full text

End of life resource utilization among patients receiving immunotherapy for advanced cancer by Burkart, J.T., Patel, S., Noonan, A.M., Monk, P., Presley, C.J., Olencki, T., Kendra, K.L., Otterson, G.A., Gustin, J., Wei, L., Owen, D.H.

Get full text

Immune related adverse events across cancer types: Incidence, risk factors and survival by Owen, D.H., Burkart, J., Patel, S., Wei, L., Tinoco, G., Liebner, D., He, K., Shields, P.G., Bertino, E.M., Presley, C.J., Johns, A., Folefac, E., Olencki, T., Carbone, D.P., Verschraegen, C., Otterson, G.A., Kendra, K.L.

Get full text

NCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM) by Moschos, S.J., Eroglu, Z., Khushalani, N.I., Kendra, K.L., Ansstas, G., In, G.K., Wang, P., Liu, G., Collichio, F.A., Arrowood, C.C., Reed, J.E., Garrett-Mead, N., Thomas, N.E., Ollila, D.W., Ivy, S.P., Ivanova, A., Dees, E.C., Abbruzzese, J.L.

Get full text